Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-01-04 @ 4:43 AM
Study NCT ID:
NCT03613532
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2018-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
Sponsor:
Jacqueline Garcia, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-07-26
First Submit QC Date:
None
Study First Post Date:
2018-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-22
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL